Here are four notes:
1. Implanet upgraded from the Pink market.
2. The company began trading on OTCQX on April 13. It used its existing stock symbol, “IMPZY.”
3. BNY Mellon is Implanet’s Principal American Liaison on OTCQX.
4. Implanet develops vertebral and knee surgery devices.
“Trading on OTCQX will allow Implanet to expand its shareholder base and visibility in the U.S. market without incurring the high costs and duplicative regulatory requirements of a U.S. stock exchange listing,” said Jason Paltrowitz, executive vice president of corporate services, OTC Markets Group.
More articles on devices:
Rush Health partners with United Airlines to provide orthopedic, spine procedures: 4 observations
Expanding Orthopedics appoints Dale Binke as VP: 3 things to know
EOS imaging’s spineEOS receives FDA approval: 4 key notes
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
